New Partnership Announcement: Clario and Trial Data bring new decentralized clinical trial solutions to the Chinese market
- Clario partners with Trial Data, a leading DCT provider, to advance patient-centric decentralized clinical trial methodologies and technologies in China.
- This collaboration combines vast DCT experience and eCOA solutions, along with deep clinical trial operations experience in China, resulting in increased capabilities and flexibility in clinical trial strategies for sponsors supporting clinical trials in China.
- Milestone partnership expands Clario’s presence in China to enhance the clinical trial landscape with innovative technology solutions.
PHILADELPHIA, PA – October 19, 2023 – Clario, a healthcare research technology company that delivers leading endpoint technology solutions for clinical trials, today announced a strategic partnership with Trial Data, a leading decentralized clinical trial (DCT) service provider, to bring innovative decentralized clinical trials solutions to the Chinese market and advance patient-centric clinical trials in China.
Decentralized clinical trial offerings are increasingly pivotal in modern clinical trial design. This collaboration combines Clario’s 25 years of DCT experience and innovative electronic Clinical Outcome Assessments (eCOA) solutions with Trial Data’s integrated DCT platform and its extensive experience in clinical trial operations in China. This partnership is set to provide sponsors supporting clinical trials in China with unparalleled access to the world’s leading solutions and, ultimately, more choice and flexibility in study protocols and for trial participants.
“Our partnership with Trial Data marks a new milestone for Clario’s expansion in China,” said, Terry Burke, Executive Vice President, electronic Clinical Outcome Assessment (eCOA), Clario. “By joining forces, we aim to combine our unique capabilities and resources to help Life Sciences companies embrace innovative technology to transform patients’ lives.”
To learn more about Clario’s eCOA Clinical Trial Solutions, please go to Clario.com.
About Clario
Clario is a leading provider of endpoint data solutions to the clinical trials industry, generating high-quality clinical evidence for our pharmaceutical, biotech, and medical device partners. We offer comprehensive evidence generation solutions that combine eCOA, cardiac solutions, medical imaging, precision motion, and respiratory endpoints.
For more than 50 years, Clario has delivered deep scientific expertise and broad endpoint technologies to help transform lives around the world. Our endpoint data solutions have supported over 26,000 clinical trials in more than 100 countries. Our global team of science, technology, and operational experts have supported over 60% of all FDA drug approvals since 2012.
For more information, go to Clario.com or follow us on LinkedIn.
Media Contact:
David Malley
Director of Brand, Content Strategy, and Communications
[email protected]